Tocilizumab User Reviews & Ratings (Page 3)
Brand names: Actemra, Tyenne, Tofidence
Tocilizumab has an average rating of 6.7 out of 10 from a total of 53 reviews on Drugs.com. 52% of reviewers reported a positive experience, while 20% reported a negative experience.
Reviews for Tocilizumab
- Lou
- Taken for 1 to 6 months
- May 15, 2019
For Juvenile Idiopathic Arthritis "Had tocilizumab intravenous monthly after 3rd month a had a grand mal seizure and diagnosed with epilepsy. I now have absence seizures, grand mal and focal seizures. I blame this medication"
- sjorg...
- April 25, 2023
For Rheumatoid Arthritis "Skin peeling on my fingers, ulcer on my tongue, high cholesterol, blood pressure, and dizzy turns."
Frequently asked questions
- What are the new drugs for rheumatoid arthritis (RA)?
- What is Actemra used to treat?
- What biosimilars have been approved in the United States?
- Is tocilizumab (Actemra) effective for treating COVID-19?
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about tocilizumab
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
- Tocilizumab drug information
- Tocilizumab (Advanced Reading)
- Tocilizumab-bavi (Advanced Reading)
- Tocilizumab (Intravenous)
- Tocilizumab Prefilled Syringes
Actemra (tocilizumab) for Juvenile Idiopathic Arthritis "After many different medicines, this medicine worked the best! Happy with results."